Sunami, E., Yamazaki, K., Shiozawa, M., Manaka, D., Kotaka, M., Sakamoto, Y., Shiomi, A., Shinohara, Y., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Yamada, J., Tanida, N., Misumi, T., Ohtsu, A., Maehara, Y., Yoshino, T. (2025). Seven-year efficacy and safety in a randomized phase III trial investigating duration of adjuvant oxaliplatin-based therapy (3 vs. 6 months) for patients with high-risk stage II colon cancer: ACHIEVE-2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.169